Sudipto Ganguly

Has grant

Assistant Professor

Johns Hopkins University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Characterizing a novel checkpoint axis in high-grade serous ovarian cancer

Open Date: 2020-02-01

Close Date: 2023-01-31

Articles (5)

Year:

2026

Aberrant microRNA expression is common in cancer, yet cell-type-specific microRNA activity in the tumor microenvironment (TME) remains poorly understood. Here, we show that germline deletion of miR-21 significantly attenuated the progression of MYC-driven prostate cancer (PCa), reducing prostate weight, tumor burden, and proliferation index in Hi-Myc mice. In situ hybridization revealed elevated miR-21 expression in multiple cell types during disease progression. Inflammatory and premalignant lesions in mouse and human prostate showed increased miR-21 in both stroma and epithelium, with further enrichment in the stroma of invasive adenocarcinoma. In Hi-Myc mice, single cell RNA-sequencing revealed miR-21 gene regulation in neoplastic, stromal, and immune cells in a cell-type-specific manner, impacting both direct and indirect targets. Notably, miR-21 deletion reduced immune infiltration into the prostate TME, particularly Trem2 -expressing macrophages and regulatory T cells. The Timp1-fibroblast gene signature in MYC-driven PCa was suppressed in miR-21 knockout prostates. Cell-cell communication analysis showed that miR-21 suppressed TGF-beta signaling in the TME, partially through Ski and Smad7 suppression in cancer-associated fibroblasts. These findings underscore the crucial role of miR-21 in PCa and provide some of the first in situ insights into cell-type-specific miRNA activity in solid tumors.

Year:

2025

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Shawn Lupold

The Catherine Iola and J. Smith Michael Distinguished Professor of Urology

Johns Hopkins University School of Medicine

UNITED STATES
View details

John Hunter

Chief Scientific Officer

-

UNITED STATES
View details

W. Nathaniel Brennen

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Tian-Li Wang

Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Srinivasan Yegnasubramanian

-

UNITED STATES
View details

Angelo De Marzo

Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details